Alector, Inc. (ALEC)
NASDAQ: ALEC · Real-Time Price · USD
2.360
+0.100 (4.42%)
Aug 21, 2026, 4:00 PM EDT - Market closed
Alector Revenue
Alector had revenue of $3.32M in the quarter ending June 30, 2026, a decrease of -57.84%. This brings the company's revenue in the last twelve months to $13.86M, down -82.91% year-over-year. In the year 2025, Alector had annual revenue of $21.05M, down -79.07%.
Revenue (ttm)
$13.86M
Revenue Growth
-82.91%
P/S Ratio
19.01
Revenue / Employee
$134,592
Employees
103
Market Cap
263.51M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 21.05M | -79.51M | -79.07% |
| Dec 31, 2024 | 100.56M | 3.50M | 3.60% |
| Dec 31, 2023 | 97.06M | -36.56M | -27.36% |
| Dec 31, 2022 | 133.62M | -73.47M | -35.48% |
| Dec 31, 2021 | 207.09M | 185.99M | 881.54% |
| Dec 31, 2020 | 21.10M | -121.00K | -0.57% |
| Dec 31, 2019 | 21.22M | -6.46M | -23.33% |
| Dec 31, 2018 | 27.68M | 23.94M | 641.02% |
| Dec 31, 2017 | 3.74M | 3.32M | 797.84% |
| Dec 31, 2016 | 416.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| MacroGenics | 175.14M |
| Niagen Bioscience | 129.08M |
| Compugen | 74.00M |
| Lineage Cell Therapeutics | 13.08M |
| Pyxis Oncology | 11.04M |
| Adagene | 9.29M |
| Whitehawk Therapeutics | 7.15M |
| Fate Therapeutics | 6.49M |
ALEC News
- 15 days ago - Alector reports Q2 EPS (21c), consensus (23c) - TheFly
- 15 days ago - Alector Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 15 days ago - Alector Quarterly report: Q2 2026 - Filings
- 15 days ago - Alector Earnings release: Q2 2026 - Filings
- 21 days ago - Alector Slides: Corporate presentation - Filings
- 6 weeks ago - Alector and GSK partnership to end after dementia, Alzheimer's drug failures - Reuters
- 3 months ago - Alector reports Q1 EPS (21c), consensus (28c) - TheFly
- 3 months ago - Alector Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire